Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Nasdaq    NDAQ

NASDAQ

(NDAQ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryAll NewsPress ReleasesOfficial PublicationsSector news

Nasdaq Indexes Lead Way on Both Sides of Atlantic

share with twitter share with LinkedIn share with facebook
08/03/2020 | 05:45am EDT

By Ben Dummett

Nasdaq Inc. is cleaning up on both sides of the Atlantic.

In the U.S., the stock-exchange operator's Nasdaq indexes are the country's best-performing major stock benchmarks this year. In Europe, the Nasdaq-owned Copenhagen exchange's index is leading the charge.

Like its U.S. counterpart, Denmark's stock exchange is thriving in a coronavirus world. But the narrower base of big stocks behind the gain could make it a riskier bet.

The Copenhagen exchange's OMX Copenhagen 20 index is largely dominated by the health-care sector. High single- and double-digit gains in three constituents -- Novo Nordisk A/S, Genmab A/S and Coloplast A/S -- all of which are health-care stocks, have helped lift the benchmark more than 13% year to date. Meanwhile, Europe's other 18 country equity benchmarks are all trading lower.

That outperformance comes as Europe battles the coronavirus-induced recession, pushing investors into so-called growth and defensive sectors. Health-care stocks are often in that group because sick people can't do without drugs and treatment. Insulin maker Novo Nordisk and Coloplast, a supplier of continence care and other products, both reported higher sales for their latest quarters, citing supply stockpiling as a reason.

Still, the concentration leaves the market index at risk of an abrupt downturn if any of these health-care companies suffer a surprise setback. Novo Nordisk, for example, carries an index weighting of 33%. That compares with a combined weighting of about 40% for the five biggest stocks in the Nasdaq Composite Index -- Apple Inc., Microsoft Corp., Amazon.com Inc., Facebook Inc. and Alphabet Inc. -- big drivers behind its outperformance in 2020. Together with Genmab, a Danish biotech company, and Coloplast, the three health-care stocks' total weighing is close to 50%.

"There is some stock-specific risk that you really need to look out for, " said Kenneth Lamont, a research analyst at Morningstar.

In 2018, Novo Nordisk fell 7.3% in one session on disappointing earnings. Danske Bank at the time blamed the sell off for a big part of a 3% drop in OMXC20 and its underperformance against rival markets that day.

The Xact OMXC25 and iShares MSCI Denmark ETF are exchange-traded funds that allow investors to bet on the Copenhagen exchange. While each ETF tracks more companies than included in the OMXC20, health-care weightings remain the biggest for each.

The OMXC25 trades at around 29 times projected earnings of the constituent companies, compared with a 10-year average of 18.6 times, according to Danske Bank, suggesting valuation is another potential risk. The growth outlook of companies such as Genmab helps to explain the richer valuation. In June, the biotech company struck a $750 million deal with AbbVie Inc. to develop cancer treatments, and the stock is up about 15% since then.

Still, Danske Bank recommends underweighting the Danish market. Growth stocks like health care are expensive, and more cyclical stocks should perform relatively better over the next three to nine months as the economy recovers, said Chief Equity Strategist Mattias Sundling.

Germany's DAX stock index, which has big weightings in industrials and autos, has gained more than 45% from its low in March, outperforming the OMXC20's 37% gain over the same period, in a possible sign of support for that view.

-- To receive our Markets newsletter every morning in your inbox, click here.

Write to Ben Dummett at ben.dummett@wsj.com

 

Stocks mentioned in the article
ChangeLast1st jan.
ABBVIE INC. 1.22% 87.28 Delayed Quote.-1.42%
ALPHABET INC. 1.36% 1458.66 Delayed Quote.8.90%
APPLE INC. 2.39% 114.96 Delayed Quote.56.59%
COLOPLAST A/S 0.51% 980 Delayed Quote.17.98%
DANSKE BANK A/S 4.58% 83.98 Delayed Quote.-25.51%
DAX 3.22% 12870.87 Delayed Quote.-2.85%
DJ INDUSTRIAL 1.51% 27584.06 Delayed Quote.-3.34%
FACEBOOK 0.78% 256.82 Delayed Quote.25.13%
GENMAB A/S 2.71% 2350 Delayed Quote.54.44%
MICROSOFT CORPORATION 0.78% 209.44 Delayed Quote.31.78%
MORNINGSTAR, INC. 1.61% 158.61 Delayed Quote.4.82%
NASDAQ 1.08% 125.37 Delayed Quote.17.06%
NASDAQ 100 1.91% 11364.449955 Delayed Quote.27.69%
NASDAQ COMP. 1.87% 11117.525026 Delayed Quote.21.63%
NOVO NORDISK A/S 0.64% 442.2 Delayed Quote.13.64%
OMX COPENHAGEN 20 1.36% 1353.6318 Delayed Quote.17.58%
S&P 500 1.61% 3351.6 Delayed Quote.2.09%
share with twitter share with LinkedIn share with facebook
All news about NASDAQ
09/25IPO Market Parties Like It's 1999
DJ
09/24NASDAQ : Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as o..
AQ
09/24Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as ..
GL
09/23CME, Nasdaq to Launch Water Futures Contract
DJ
09/21NASDAQ : Delisting of Securities of Therapix Biosciences Ltd.; Stein Mart, Inc.;..
AQ
09/21Delisting of Securities of Therapix Biosciences Ltd.; Stein Mart, Inc.; and S..
GL
09/21Wall Street-backed MEMX launches in challenge to NYSE and Nasdaq
RE
09/21WALL STREET STOCK EXCHANGE : Wall Street-Backed Exchange Launches as Rival to NY..
DJ
09/21NASDAQ : Launches Purpose Initiative to Advance Inclusive Growth and Prosperity
AQ
09/21Nasdaq Launches Purpose Initiative to Advance Inclusive Growth and Prosperity
GL
More news
Financials (USD)
Sales 2020 2 774 M - -
Net income 2020 923 M - -
Net Debt 2020 2 127 M - -
P/E ratio 2020 23,1x
Yield 2020 1,56%
Capitalization 20 373 M 20 373 M -
EV / Sales 2020 8,11x
EV / Sales 2021 7,86x
Nbr of Employees 4 670
Free-Float 67,0%
Chart NASDAQ
Duration : Period :
Nasdaq Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NASDAQ
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 135,92 $
Last Close Price 124,03 $
Spread / Highest target 20,9%
Spread / Average Target 9,58%
Spread / Lowest Target -23,4%
EPS Revisions
Managers
NameTitle
Adena T. Friedman President, Chief Executive Officer, COO & Director
Michael R. Splinter Chairman
Michael Ptasznik Chief Financial Officer & EVP-Corporate Strategy
Bradley J. Peterson Chief Information Officer & Executive VP
Lars Rune Wedenborn Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
NASDAQ15.81%20 373
HONG KONG EXCHANGES AND CLEARING LIMITED40.63%58 056
INTERCONTINENTAL EXCHANGE, INC.8.65%56 439
LONDON STOCK EXCHANGE PLC12.59%38 898
DEUTSCHE BÖRSE AG4.89%31 328
B3 S.A. - BRASIL, BOLSA, BALCÃO33.47%21 037